A Case of Allgrove Syndrome with a Novel IVS7 +1 G>A Mutation of The AAAS Gene

「Introduction」 Allgrove syndrome, also known as triple A syndrome (OMIM #231550), is a rare autosomal recessive disorder characterized by the triad of adrenocorticotropic hormone (ACTH)-resistant adrenal insufficiency, achalasia and alacrima. It is caused by mutations of the AAAS gene, which is loca...

Full description

Saved in:
Bibliographic Details
Published inClinical Pediatric Endocrinology Vol. 21; no. 1; pp. 11 - 13
Main Authors Satoru Ikemoto, Ken Sakurai, Naruo Kuwashima, Yoshihiro Saito, Ichiro Miyata, Noriyuki Katsumata, Hiroyuki Ida
Format Journal Article
LanguageJapanese
Published The Japanese Society for Pediatric Endocrinology 01.01.2012
Online AccessGet full text

Cover

More Information
Summary:「Introduction」 Allgrove syndrome, also known as triple A syndrome (OMIM #231550), is a rare autosomal recessive disorder characterized by the triad of adrenocorticotropic hormone (ACTH)-resistant adrenal insufficiency, achalasia and alacrima. It is caused by mutations of the AAAS gene, which is located on chromosome 12q13, encoding the WD-repeat protein ALADIN (alacrima-achalasia-adrenal insufficiency neurologic disorder) (1). Herein, we present a case of a two-year-old girl with a genetically confirmed diagnosis of Allgrove syndrome resulting from a novel homozygous mutation of the AAAS gene. 「Patient Report」 The patient is a two-year-old Japanese girl born from consanguineous parents. She was born at term after an uncomplicated pregnancy. There was a consistent history of alacrima since birth. At the age of two years, she presented with generalized tonic-clonic seizure with hypoglycemia (<20 mg/dl) and IV glucose infusion was initiated. However, she had no history of gastrointestinal problems.
ISSN:0918-5739